As every investor would know, not every swing hits the sweet spot. But really bad investments should be rare. So ...

THIS WEEKEND TO TALK ABOUT BLOOD CANCER. THE LATEST UPDATES AND RESOURCES FOR FINANCIAL HELP FOR PATIENTS AND THEIR FAMILIES. JOINING ME NOW FROM THE LEUKEMIA, LEUKEMIA AND LYMPHOMA SOCIETY IS ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women ...

Healthcare diagnostics equipment manufacturer, Idexx Laboratories (NASDAQ: IDXX), is the global leader in pet care. Despite ...

To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...

The students' efforts will help fund critical blood cancer research while supporting essential patient services, including mental health programs, financial assistance and transportation services ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

These approaches are being investigated in various types of cancer, including breast and lung cancers and glioblastoma. The Vall d’Hebron Institute of Oncology (VHIO) and Hospital del Mar ...

and an endometrial cancer test from Acrivon Therapeutics. Two Alzheimer’s blood tests, one from Spear Bio and another from Beckman Coulter, were also designated breakthroughs. Most of the ...

Olvi-Vec is being developed as a platinum resensitizing agent for multiple cancers, including ovarian and non-small cell lung cancer. The ongoing trial in China informs phase 2 design, aiming to ...